Molecular Formula | C16H15N3O3 |
Molar Mass | 297.31 |
Density | 1.336±0.06 g/cm3(Predicted) |
Boling Point | 476.5±40.0 °C(Predicted) |
pKa | 9.58±0.10(Predicted) |
Storage Condition | 2-8°C(protect from light) |
MDL | MFCD02683970 |
In vivo study | WHI-P180 is also an active inhibitor of IgE-mediated mast cell responses. The elimination half-life of WHI-P180 in CD-1 mice (BALB/c mice) following i.v., i.p., or p.o. administration is less than 10 min. Systemic clearance of WHI-P180 is 6742 mL/h/kg in CD-I mice and 8188 mL/h/kg in BALB/c mice. Notably, WHI-P180, when administered in two consecutive nontoxic i.p. bolus doses of 25 mg/kg, inhibits IgE/antigen-induced vascular hyperpermeability in a well-characterized murine model of passive cutaneous anaphylaxis. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.363 ml | 16.817 ml | 33.635 ml |
5 mM | 0.673 ml | 3.363 ml | 6.727 ml |
10 mM | 0.336 ml | 1.682 ml | 3.363 ml |
5 mM | 0.067 ml | 0.336 ml | 0.673 ml |
biological activity | WHI-P180 is an inhibitor of multiple kinases, and the IC50 values for RET (c-RET) and KDR are 4.5 nM and 66 nM respectively. |
Target | Value |
RET (Cell-free assay) | 4.5 nM |
KDR (Cell-free assay) | 66 nM |